<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Spejo AB</submitter><funding>Conselho Nacional de Desenvolvimento Científico e Tecnológico</funding><funding>Fundação de Amparo à Pesquisa do Estado de São Paulo</funding><pagination>230</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6092804</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Treatment of spinal cord injury is dependent on neuronal survival, appropriate synaptic circuit preservation, and inflammatory environment management. In this sense, mesenchymal stem cell (MSC) therapy is a promising tool that can reduce glial reaction and provide trophic factors to lesioned neurons.&lt;h4>Methods&lt;/h4>Lewis adult female rats were submitted to a unilateral ventral funiculus cut at the spinal levels L4, L5, and L6. The animals were divided into the following groups: IA (intramedullary axotomy), IA + DMEM (Dulbecco's modified Eagle's medium), IA + FS (fibrin sealant), IA + MSC (10&lt;sup>6&lt;/sup> cells), and IA + FS + MSC (10&lt;sup>6&lt;/sup> cells). Seven days after injury, qPCR (n = 5) was performed to assess gene expression of VEGF, BDNF, iNOS2, arginase-1, TNF-α, I</pubmed_abstract><journal>Journal of neuroinflammation</journal><pubmed_title>Neuroprotection and immunomodulation following intraspinal axotomy of motoneurons by treatment with adult mesenchymal stem cells.</pubmed_title><pmcid>PMC6092804</pmcid><funding_grant_id>303085/2017-7</funding_grant_id><funding_grant_id>2014/06892-3</funding_grant_id><funding_grant_id>300553/2013-9</funding_grant_id><funding_grant_id>2013/16168-8</funding_grant_id><funding_grant_id>2012/22750-9</funding_grant_id><pubmed_authors>Gomes DA</pubmed_authors><pubmed_authors>Chiarotto GB</pubmed_authors><pubmed_authors>Barraviera B</pubmed_authors><pubmed_authors>Ferreira RS</pubmed_authors><pubmed_authors>Spejo AB</pubmed_authors><pubmed_authors>Ferreira ADF</pubmed_authors><pubmed_authors>Oliveira ALR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neuroprotection and immunomodulation following intraspinal axotomy of motoneurons by treatment with adult mesenchymal stem cells.</name><description>&lt;h4>Background&lt;/h4>Treatment of spinal cord injury is dependent on neuronal survival, appropriate synaptic circuit preservation, and inflammatory environment management. In this sense, mesenchymal stem cell (MSC) therapy is a promising tool that can reduce glial reaction and provide trophic factors to lesioned neurons.&lt;h4>Methods&lt;/h4>Lewis adult female rats were submitted to a unilateral ventral funiculus cut at the spinal levels L4, L5, and L6. The animals were divided into the following groups: IA (intramedullary axotomy), IA + DMEM (Dulbecco's modified Eagle's medium), IA + FS (fibrin sealant), IA + MSC (10&lt;sup>6&lt;/sup> cells), and IA + FS + MSC (10&lt;sup>6&lt;/sup> cells). Seven days after injury, qPCR (n = 5) was performed to assess gene expression of VEGF, BDNF, iNOS2, arginase-1, TNF-α, I</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Aug</publication><modification>2025-04-19T10:56:58.101Z</modification><creation>2019-03-26T23:51:43Z</creation></dates><accession>S-EPMC6092804</accession><cross_references><pubmed>30107848</pubmed><doi>10.1186/s12974-018-1268-4</doi></cross_references></HashMap>